共 50 条
Synthesis and biological evaluation of novel 6,11-dihydro-5H-benzo[e] pyrimido- [5,4-b][1,4]diazepine derivatives as potential c-Met inhibitors
被引:17
|作者:
Huang, Daowei
[1
,2
]
Huang, Lei
[1
,2
]
Zhang, Qingwei
[1
,2
]
Li, Jianqi
[1
,2
]
机构:
[1] Shanghai Inst Pharmaceut Ind, Novel Technol Ctr Pharmaceut Chem, Shanghai 201203, Peoples R China
[2] Shanghai Engn Res Ctr Pharmaceut Proc, Shanghai 201203, Peoples R China
基金:
中国国家自然科学基金;
关键词:
c-Met;
tyrosine kinase;
Diazepine derivatives;
Synthesis;
Antitumor;
RECEPTOR TYROSINE KINASE;
GROWTH-FACTOR RECEPTOR;
SMALL-MOLECULE INHIBITOR;
ANTITUMOR-ACTIVITY;
DUAL INHIBITORS;
IN-VIVO;
DESIGN;
MOIETY;
DISCOVERY;
BEARING;
D O I:
10.1016/j.ejmech.2017.08.060
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Over expression of c-Met tyrosine kinase is known to promote tumorigenesis and metastasis, as well as to cause therapeutic resistance. Herein a series of novel 6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4] diazepine derivatives were designed, synthesised and evaluated for their c-Met kinase inhibition. Compounds 17e, 17f, 18a, and 18b were further examined for their anti-proliferative activities against four typical cancer cell lines (PC-3, Panc-1, HepG2, and Caki-1). The promising compound 17f was identified as a multi-target receptor tyrosine kinase inhibitor, which also displayed favourable pharmacokinetic properties in rats, had an acceptable safety profile in preclinical studies, and significant anti tumour activity in the Caki-1 tumour xenograft model. (C) 2017 Published by Elsevier Masson SAS.
引用
收藏
页码:212 / 228
页数:17
相关论文